114 drugs pass bioequivalence testing in first half

Published: 2011-07-18 06:59:00
Updated: 2011-07-18 06:59:00
The Korea Food and Drug Administration said Thursday that it approved a total of 114 bioequivalence-endorsed medicines in the first half of this year, down 35 percent compared with 176 drugs in the same period of last year.

By active ingredient, pregabalin led any others with 20 cases, followe...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.